Heparin Market
- 2026 年市場規模
- USD 7,500 Mn
- 2033 年預估規模
- USD 10,000 Mn
- 年複合成長率 CAGR
- 4.8%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Heparin Market, By Product Type (Unfractionated Heparin (UH), Low Molecular Weight Heparin (LMWH), and Ultra-low Molecular Weight Heparin (ULMW)), By Dosage Form (Injection, and Solutions), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Heparin is an anticoagulant used to decrease the clotting ability of blood and help to prevent harmful clots from forming in blood vessels. It is sometimes referred as a blood thinner, although it does not actually thin the blood. Heparin does not dissolve already formed blood clots, but it can prevent the clots from becoming larger and causing more serious problems. Pharmaceutical-grade heparin is derived from animal tissue. Heparin is commonly used in the treatment of coronary heart disease, pulmonary embolism, deep vein thrombosis, and atrial fibrillation, and in the prevention of thrombosis during extracorporeal membrane oxygenation and cardiopulmonary bypass.
Market Dynamics
Rising cases of conditions such as coronary heart disease, pulmonary embolism, and deep vein thrombosis is one of the major factors for increased demand of heparin drugs in the market. Myocardial infarction (MI) is one of the major complications of coronary heart disease. According to the American Heart Association 2018 report, coronary heart disease is the leading cause (43.8%) of deaths due to cardiovascular disease in the U.S., followed by stroke (16.8%). As per the Centres for Disease Control and Prevention (CDC) 2015 report, deep vein thrombosis affects nearly 900,000 individuals in the U.S. each year.
Despite major applications in chronic conditions, heparin is poorly absorbed by the intestine, therefore it must be given intravenously or subcutaneously. Moreover, the drug creates a significant risk of excessive bleeding due to anticlotting effect. Heparin also induce conditions such as thrombocytopenia (reduced number of circulating platelets) and hypersensitivity reactions. These factors can hamper the heparin market, during the forecast period.
Key features of the study
• This report provides in-depth analysis of the heparin market, market size (USD Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global heparin market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include Anselm Pharmaceuticals, Baxter International Inc., B. Braun Melsungen AG, Bristol-Myers Squibb Co., Dr. Reddy’s Laboratories Ltd., Fresenius SE & Co. KGaA, Leap Labchem Co., LEO Pharma A/S, Pfizer, Inc., Sanofi S.A., Syntex S.A., Teva Pharmaceutical Industries Ltd., and United Biotech (P) Ltd.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global heparin market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for heparin market, research and consulting firms, new entrants, and financial analysts
Market Segmentation
• Product Type Insights (Revenue, USD Mn, 2026 - 2033)
o Unfractionated Heparin (UH)
o Low Molecular Weight Heparin (LMWH)
o Ultra-low Molecular Weight Heparin (ULMW)
• Dosage Form Insights (Revenue, USD Mn, 2026 - 2033)
o Injection
o Solutions
• Regional Insights (Revenue, USD Mn, 2026 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
North Africa
Central Africa
South Africa
• Key Players Insights
o Anselm Pharmaceuticals
o Baxter International Inc.
o B. Braun Melsungen AG
o Bristol-Myers Squibb Co.
o Dr. Reddy’s Laboratories Ltd.
o Fresenius SE & Co. KGaA
o Leap Labchem Co.
o LEO Pharma A/S
o Pfizer, Inc.
o Sanofi S.A.
o Syntex S.A.
o Teva Pharmaceutical Industries Ltd.
o United Biotech (P) Ltd.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Global Heparin Market, By Product Type
Global Heparin Market, By Dosage Form
Global Heparin Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Key Developments
o Industry Trend
4. Global Heparin Market, By Product Type, 2020-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Unfractionated Heparin (UH)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
o Low Molecular Weight Heparin (LMWH)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
o Ultra-low Molecular Weight Heparin (ULMW)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
5. Global Heparin Market, By Dosage Form, 2020-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Injection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
o Solutions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
6. Global Heparin Market, By Region, 2020 - 2033, Value (USD Mn)
o Introduction
Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Mn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Dosage Form, 2020 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
o South Africa
o North Africa
o Central Africa
7. Competitive Landscape
o Anselm Pharmaceuticals
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Baxter International Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o B. Braun Melsungen AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Bristol-Myers Squibb Co.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Dr. Reddy’s Laboratories Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Fresenius SE & Co. KGaA
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Leap Labchem Co.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o LEO Pharma A/S
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Pfizer, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Sanofi S.A.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Syntex S.A.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Teva Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o United Biotech (P) Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
8. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
9. References and Research Methodology
o References
o Research Methodology
o About us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們